Oxygenta Pharmaceutical Ltd. - Research Center
524636 OXYGENTAPH Group (XT) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Sales |
19.94 |
14.95 |
23.01 |
37.52 |
11.85 |
Operating profit |
-5.61 |
-2.54 |
-0.59 |
2.07 |
-0.03 |
Interest |
0.64 |
0.35 |
0.38 |
0.54 |
0.26 |
Gross profit |
-6.25 |
-2.89 |
-0.97 |
1.53 |
-0.28 |
EPS (Rs) |
-2.31 |
-2.84 |
-0.49 |
0.06 |
-0.76 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Mar ' 22 |
Sep ' 21 |
Sep ' 20 |
Other income |
- |
- |
- |
- |
0.01 |
Stock adjustment |
-1.21 |
-1.90 |
2.92 |
1.63 |
-7.34 |
Raw material |
19.76 |
12.66 |
14.49 |
28.19 |
15.22 |
Power and fuel |
- |
- |
- |
- |
- |
Employee expenses |
0.50 |
0.43 |
0.15 |
0.18 |
0.31 |
Excise |
- |
- |
- |
- |
- |
Admin and selling expenses |
- |
- |
- |
- |
- |
Research and development expenses |
- |
- |
- |
- |
- |
Expenses capitalised |
- |
- |
- |
- |
- |
Other expenses |
6.49 |
6.31 |
6.05 |
5.45 |
3.69 |
Provisions made |
- |
- |
- |
- |
- |
Depreciation |
1.33 |
0.80 |
0.79 |
0.81 |
0.50 |
Taxation |
-0.02 |
- |
0.12 |
- |
- |
Net profit / loss |
-7.72 |
-4.03 |
-0.70 |
0.09 |
-0.78 |
Extra ordinary item |
-0.16 |
-0.34 |
1.18 |
-0.64 |
- |
Prior year adjustments |
- |
- |
- |
- |
- |
Equity capital |
33.48 |
14.20 |
14.20 |
14.20 |
10.20 |
Equity dividend rate |
- |
- |
- |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
- |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
- |
- |
- |
OPM (%) |
-28.14 |
-17.02 |
-2.58 |
5.52 |
-0.28 |
GPM (%) |
-31.32 |
- |
-4.23 |
4.08 |
-2.35 |
NPM (%) |
-38.71 |
- |
-3.03 |
0.23 |
-6.57 |